UB Paderborn / Katalog / Suche / in CDI

Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study

International journal of infectious diseases, 2017-04, Vol.57 (C), p.27-31

2017

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “Risk Factors for 30-Day Mortality in Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infections” [International Journal of Infectious Diseases, 61 (2017) 3-6]

International journal of infectious diseases, 2024-07, Vol.144, p.107093-107093, Article 107093

2024

Link zum Volltext

Verfügbarkeit prüfen

Emerging Issues and Treatment Strategies in Carbapenem-Resistant Enterobacteriaceae (CRE)

Current Infectious Disease Reports, 2016-12, Vol.18 (12), p.48-48, Article 48

2016

Link zum Volltext

Verfügbarkeit prüfen

Penicillin plus Ceftriaxone versus Ampicillin plus Ceftriaxone Synergistic Potential against Clinical Enterococcus faecalis Blood Isolates

Microbiology spectrum, 2022-06, Vol.10 (4), p.e0062122

2022

Link zum Volltext

Verfügbarkeit prüfen

Glycopeptide Hypersensitivity and Adverse Reactions

Pharmacy, 2020-04, Vol.8 (2), p.70

2020

Link zum Volltext

Verfügbarkeit prüfen

Risk Factors for 30-Day Mortality in Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infections

International journal of infectious diseases, 2017-08, Vol.61 (C), p.3-6

2017

Link zum Volltext

Verfügbarkeit prüfen

Antibiotic Hypersensitivity Mechanisms

Pharmacy, 2019-08, Vol.7 (3), p.122

2019

Link zum Volltext

Verfügbarkeit prüfen

Characterization of heterogeneous vancomycin-intermediate resistance, MIC and accessory gene regulator (agr) dysfunction among clinical bloodstream isolates of staphyloccocus aureus

BMC infectious diseases, 2011-10, Vol.11 (1), p.287-287, Article 287

2011

Link zum Volltext

Verfügbarkeit prüfen

726. Risk factor analysis for cefepime and piperacillin/tazobactam resistant organisms

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureus

International journal of antimicrobial agents, 2010-01, Vol.35 (1), p.25-29

2010

Link zum Volltext

Verfügbarkeit prüfen

Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae Infections

Antimicrobial agents and chemotherapy, 2017-07, Vol.61 (7)

2017

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamics of Cefepime Alone and in Combination with Various Antimicrobials against Methicillin-Resistant Staphylococcus aureus in an In Vitro Pharmacodynamic Infection Model

Antimicrobial Agents and Chemotherapy, 2005-01, Vol.49 (1), p.302-308

2005

Link zum Volltext

Verfügbarkeit prüfen

731. Factors Contributing to Long-Term Risk of Developing Multidrug-Resistant Pseudomonas Recurrence

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Link zum Volltext

Verfügbarkeit prüfen

The Emerging Role of β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections

Antimicrobial agents and chemotherapy, 2020-06, Vol.64 (7)

2020

Link zum Volltext

Verfügbarkeit prüfen

Perspectives: potential therapeutic options for SARS-CoV-2 patients based on feline infectious peritonitis strategies: central nervous system invasion and drug coverage

International journal of antimicrobial agents, 2020-06, Vol.55 (6), p.105964-105964, Article 105964

2020

Link zum Volltext

Verfügbarkeit prüfen

121. Evaluation of Multifaceted Antimicrobial Stewardship in Optimizing Antimicrobial Usage in Intraabdominal Infection at a Community Hospital

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S174-S174

2021

Link zum Volltext

Verfügbarkeit prüfen

681. Penicillin Plus Ceftriaxone Against Enterococcus faecalis In Vitro Time-Kill Studies

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S443-S444

2021

Link zum Volltext

Verfügbarkeit prüfen

Cleaning and disinfecting environmental surfaces in health care: Toward an integrated framework for infection and occupational illness prevention

American journal of infection control, 2015-05, Vol.43 (5), p.424-434

2015

Link zum Volltext

Verfügbarkeit prüfen

Optimizing outcomes using vancomycin therapeutic drug monitoring in patients with MRSA bacteremia: trough concentrations or area under the curve?

Diagnostic microbiology and infectious disease, 2021-10, Vol.101 (2), p.115442, Article 115442

2021

Link zum Volltext

Verfügbarkeit prüfen

172. Evaluation of Multifaceted Antimicrobial Stewardship Interventions on The Treatment of Asymptomatic Bacteriuria

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S93-S94

2020

Link zum Volltext

Verfügbarkeit prüfen

The Risk of Acute Kidney Injury in Critically Ill Patients Receiving Concomitant Vancomycin With Piperacillin–Tazobactam or Cefepime

Journal of intensive care medicine, 2020-12, Vol.35 (12), p.1434-1438

2020

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activities of a Novel Cephalosporin, CB-181963 (CAB-175), against Methicillin-Susceptible or -Resistant Staphylococcus aureus and Glycopeptide-Intermediate Susceptible Staphylococci

Antimicrobial Agents and Chemotherapy, 2004-07, Vol.48 (7), p.2719-2723

2004

Link zum Volltext

Verfügbarkeit prüfen

Resistance to Non-glycopeptide Agents in Serious Staphylococcus aureus Infections

Current Infectious Disease Reports, 2016-12, Vol.18 (12), p.47-47, Article 47

2016

Link zum Volltext

Verfügbarkeit prüfen

227. Evaluation of Empiric Vancomycin Utilization at 72 Hours Post Admission: is De-escalation of Vancomycin Appropriate?

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S114-S115

2020

Link zum Volltext

Verfügbarkeit prüfen

Risk of Serotonin Syndrome with Concomitant Administration of Linezolid and Serotonin Agonists

Pharmacotherapy, 2006-12, Vol.26 (12), p.1784-1793

2006

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study

Corrigendum to “Risk Factors for 30-Day Mortality in Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infections” [International Journal of Infectious Diseases, 61 (2017) 3-6]

Emerging Issues and Treatment Strategies in Carbapenem-Resistant Enterobacteriaceae (CRE)

Penicillin plus Ceftriaxone versus Ampicillin plus Ceftriaxone Synergistic Potential against Clinical Enterococcus faecalis Blood Isolates

Glycopeptide Hypersensitivity and Adverse Reactions

Risk Factors for 30-Day Mortality in Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infections

Antibiotic Hypersensitivity Mechanisms

Characterization of heterogeneous vancomycin-intermediate resistance, MIC and accessory gene regulator (agr) dysfunction among clinical bloodstream isolates of staphyloccocus aureus

726. Risk factor analysis for cefepime and piperacillin/tazobactam resistant organisms

Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureus

Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae Infections

Pharmacodynamics of Cefepime Alone and in Combination with Various Antimicrobials against Methicillin-Resistant Staphylococcus aureus in an In Vitro Pharmacodynamic Infection Model

731. Factors Contributing to Long-Term Risk of Developing Multidrug-Resistant Pseudomonas Recurrence

The Emerging Role of β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections

Perspectives: potential therapeutic options for SARS-CoV-2 patients based on feline infectious peritonitis strategies: central nervous system invasion and drug coverage

121. Evaluation of Multifaceted Antimicrobial Stewardship in Optimizing Antimicrobial Usage in Intraabdominal Infection at a Community Hospital

681. Penicillin Plus Ceftriaxone Against Enterococcus faecalis In Vitro Time-Kill Studies

Cleaning and disinfecting environmental surfaces in health care: Toward an integrated framework for infection and occupational illness prevention

Optimizing outcomes using vancomycin therapeutic drug monitoring in patients with MRSA bacteremia: trough concentrations or area under the curve?

172. Evaluation of Multifaceted Antimicrobial Stewardship Interventions on The Treatment of Asymptomatic Bacteriuria

The Risk of Acute Kidney Injury in Critically Ill Patients Receiving Concomitant Vancomycin With Piperacillin–Tazobactam or Cefepime

In Vitro Activities of a Novel Cephalosporin, CB-181963 (CAB-175), against Methicillin-Susceptible or -Resistant Staphylococcus aureus and Glycopeptide-Intermediate Susceptible Staphylococci

Resistance to Non-glycopeptide Agents in Serious Staphylococcus aureus Infections

227. Evaluation of Empiric Vancomycin Utilization at 72 Hours Post Admission: is De-escalation of Vancomycin Appropriate?

Risk of Serotonin Syndrome with Concomitant Administration of Linezolid and Serotonin Agonists

Suchergebnisse filtern